X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA PFIZER NATCO PHARMA/
PFIZER
 
P/E (TTM) x 30.8 28.2 109.2% View Chart
P/BV x 23.3 4.5 520.3% View Chart
Dividend Yield % 0.5 0.7 67.9%  

Financials

 NATCO PHARMA   PFIZER
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
PFIZER
Mar-16
NATCO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8772,724 32.2%   
Low Rs4241,611 26.3%   
Sales per share (Unadj.) Rs223.4440.9 50.7%  
Earnings per share (Unadj.) Rs31.148.7 63.8%  
Cash flow per share (Unadj.) Rs40.375.8 53.2%  
Dividends per share (Unadj.) Rs5.0015.00 33.3%  
Dividend yield (eoy) %0.80.7 111.1%  
Book value per share (Unadj.) Rs219.5462.9 47.4%  
Shares outstanding (eoy) m33.0745.75 72.3%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.94.9 59.2%   
Avg P/E ratio x20.944.5 47.0%  
P/CF ratio (eoy) x16.128.6 56.4%  
Price / Book Value ratio x3.04.7 63.3%  
Dividend payout %16.130.8 52.2%   
Avg Mkt Cap Rs m21,50499,163 21.7%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m1,1282,758 40.9%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m7,38920,170 36.6%  
Other income Rs m167857 19.5%   
Total revenues Rs m7,55621,028 35.9%   
Gross profit Rs m1,7934,310 41.6%  
Depreciation Rs m3041,239 24.6%   
Interest Rs m3665 7,042.3%   
Profit before tax Rs m1,2903,923 32.9%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m3091,794 17.2%   
Profit after tax Rs m1,0272,228 46.1%  
Gross profit margin %24.321.4 113.6%  
Effective tax rate %23.945.7 52.3%   
Net profit margin %13.911.0 125.9%  
BALANCE SHEET DATA
Current assets Rs m3,68116,299 22.6%   
Current liabilities Rs m3,1237,594 41.1%   
Net working cap to sales %7.643.2 17.5%  
Current ratio x1.22.1 54.9%  
Inventory Days Days8965 137.1%  
Debtors Days Days5926 227.9%  
Net fixed assets Rs m7,6858,622 89.1%   
Share capital Rs m331458 72.3%   
"Free" reserves Rs m6,67020,722 32.2%   
Net worth Rs m7,25921,180 34.3%   
Long term debt Rs m95525 3,819.6%   
Total assets Rs m11,95729,137 41.0%  
Interest coverage x4.5755.5 0.6%   
Debt to equity ratio x0.10 11,144.9%  
Sales to assets ratio x0.60.7 89.3%   
Return on assets %11.77.7 152.1%  
Return on equity %14.210.5 134.6%  
Return on capital %20.719.0 109.1%  
Exports to sales %39.40.1 66,147.4%   
Imports to sales %5.717.5 32.6%   
Exports (fob) Rs m2,90812 24,231.7%   
Imports (cif) Rs m4213,526 11.9%   
Fx inflow Rs m3,44552 6,670.7%   
Fx outflow Rs m703140 502.1%   
Net fx Rs m2,743-88 -3,104.9%   
CASH FLOW
From Operations Rs m1,4403,436 41.9%  
From Investments Rs m-1,089-6,991 15.6%  
From Financial Activity Rs m-353-619 57.0%  
Net Cashflow Rs m-1-4,174 0.0%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 1.5 63.9 2.3%  
Indian inst/Mut Fund % 7.8 7.5 104.5%  
FIIs % 16.6 4.9 339.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 23.7 109.7%  
Shareholders   25,395 85,207 29.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex & Nifty Open at Record Highs; Banking & PSU Stocks Rally(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.46% while the Hang Seng is up 0.28%. The Shanghai Composite is trading up by 0.43%.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 18, 2018 10:11 AM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - DIVIS LABORATORIES COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS